THAT — Thalia Therapeutics Share News
0.000.00%
Last trade - 00:00- £11.10m
- £9.59m
- £0.01m
Holding(s) in Company
Brief: N4 Pharma Says Transduction Efficacy Rose 2.5-Fold When Viral Vector Complexed With Nuvec Vs AAV8 Vector Used On Standalone Basis
AAV Viral Vector Update
Holding(s) in Company
Nuvec® R&D and Strategy Update
N4 Pharma Launches New Interactive Investor Hub
Investor Presentation via Investor Meet Company
Holding(s) in Company
Investor Presentation
Acquisition of Controlling Interest in Nanogenics
Interim Results
UK's N4 Pharma rises on US patent nod
Brief: N4 Pharma Says US Patent Attorney Granting Further Patent Application For Nuvec In U.S.
Grant Award for Professor Chengzhong Yu
siRNA update
siRNA update
Brief: N4 Pharma PLC Says Operating Loss For Year Reduced To £1,029,261
Posting of Annual Report & Notice of AGM
Final Results